Bayer shareholders on Friday cast a vote of disapproval of the German drugmaker's top management amid anger over a stock price slump as litigation risks mount from the $63 billion takeover of seed maker Monsanto.

from Reuters: Business News https://reut.rs/2GBjw17
via IFTTT
from Reuters: Business News https://reut.rs/2GBjw17
via IFTTT
Post a Comment